Significantly increased LINC00460 level was reported in pancreatic cancer (PC) patients as compared to the healthy controls, indicating that LINC00460 has the potential to be used as an effective biomarker of prognosis and diagnosis of PC [8]. Here, LINC00460 is linked to pachyonychia congenita.